免疫学技术和临床__培训课件.pptVIP

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * This slide illustrates how the use and the positioning of cardiac troponin has evolved since the assays became first available and the original clinical studies were performed. Initially, troponin was thought to be a marker of AMI and, in this function allow to differentiate AMI from non-AMI patients. The availability of more sensitive assays and the results of large well-designed clinical studies have shown that a subset of unstable angina patients shown to have detectable troponin levels were at greater risk of future adverse cardiac